Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $832.5200 (1.95%) ($819.5900 - $840.3300) on Mon. Nov. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.14% (three month average) | RSI | 46 | Latest Price | $832.5200(1.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.4% a day on average for past five trading days. | Weekly Trend | REGN declines -0.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(59%) IBB(50%) SPY(46%) SDY(45%) SPLV(45%) | Factors Impacting REGN price | REGN will decline at least -0.57% in a week (0% probabilities). VXX(-42%) VIXM(-27%) TBT(-20%) UNG(-16%) SKYY(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.57% (StdDev 1.14%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $807.56(3.09%) | 10 Day Moving Average | $798.89(4.21%) | 20 Day Moving Average | $811.55(2.58%) | To recent high | -1.5% | To recent low | 7.5% | Market Cap | $88.271b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |